Glioma stem-like cells (GSCs) were first described as a population which may in part be
resistant to traditional chemotherapeutic therapies and responsible for tumour regrowth …

Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in adults.
Although the overall incidence is less than 10 per 100,000 individuals, its poor prognosis …

Metastatic cancers require further diagnosis to determine their primary tumor sites. However,
the tissue-of-origin for around 5% tumors could not be identified by routine medical …

Carcinoma of unknown primary (CUP), defined as metastatic cancers with unknown cancer
origin, occurs in 3‐5 per 100 cancer patients in the United States. Heterogeneity and …

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Ma... : Medicine Isocitrate
Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas …

Gliomas are the second most common primary brain tumors in adults. They are treated with
combination therapies, including surgery, radiotherapy, and chemotherapy. There are …

Backgrounds Mutations in the isocitrate dehydrogenase (IDH) 1 gene are favourable
prognostic factors in newly diagnosed diffuse gliomas, whereas it remains controversial in …

Background The purpose of this study was to evaluate the feasibility of using a short echo
time, three‐dimensional H‐1 magnetic resonance spectroscopic imaging (MRSI) sequence …

Magnetic resonance spectroscopy (MRS) is a powerful tool for noninvasively investigating
normal and abnormal metabolism. When used in combination with imaging strategies …

We studied 36 glioblastoma cases at HC-UNICAMP from 2008 to 2012 and classified the
immunohistochemical distribution of the wild-type epidermal growth factor receptor (EGFR) …